Exposure-response analysis using time-to-event data for bevacizumab biosimilar SB8 and the reference bevacizumab
Purpose: This analysis aimed to characterize the exposure-response relationship of bevacizumab in non-small-cell lung cancer (NSCLC) and evaluate the efficacy of SB8, a bevacizumab biosimilar, and Avastin®, the reference bevacizumab sourced from the European Union (EU), based on the exposure reporte...
Saved in:
Main Authors: | Suemin Park (Author), Jin Ah Jung (Author), Sungil Ju (Author), Hyeong-Seok Lim (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
by: Di Cao, et al.
Published: (2023) -
Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab
by: B. Miguel‐Lillo, et al.
Published: (2023) -
Bevacizumab for glioblastoma
by: Narita Y
Published: (2015) -
A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab
by: C. Schwabe, et al.
Published: (2023) -
Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
by: Shu-Ping Lee, et al.
Published: (2019)